Another trial with positive results in stage IV melanoma patients used a hapten modified vaccine, MVax (a vaccine prepared form the patients’ own cancer cells mixed with BCG and used in combination with cyclophosphamide followed by IL-2) [31]. This evidence concerns the gene IL2 and cancer.